Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Sell
1,765
-6,261
-78% -$1.57M 0.01% 848
2025
Q4
$2.28M Buy
8,026
+2,752
+52% +$860K 0.05% 339
2025
Q3
$1.79M Buy
+5,274
New +$1.65M 0.04% 377
2025
Q1
$200K Sell
762
-287
-27% -$77.7K 0.01% 1013
2024
Q4
$274K Buy
+1,049
New +$264K 0.01% 839
2023
Q1
Sell
-868
Closed -$256K 666
2022
Q4
$256K Buy
+868
New +$239K 0.02% 443
2022
Q3
Sell
-1,073
Closed -$234K 603
2022
Q2
$234K Sell
1,073
-60
-5% -$13.6K 0.02% 455
2022
Q1
$302K Sell
1,133
-226
-17% -$55.5K 0.03% 419
2021
Q4
$362K Buy
+1,359
New +$394K 0.03% 364

Other funds holding PODD

Caprock Group's PODD Position: Q1 2026 in Review

Caprock Group reduced its Insulet (PODD) stake by 78% in Q1 2026, selling an estimated $1.57M and leaving 1,765 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #848.

Caprock Group first reported a position in PODD in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.28M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Caprock Group held 1,765 shares of Insulet worth $371K as of Q1 2026.
  • Caprock Group sold 6,261 Insulet shares in Q1 2026, an estimated $1.57M.
  • Insulet made up 0.01% of Caprock Group's portfolio in Q1 2026, its #848 holding.
  • Caprock Group first reported a position in Insulet in Q4 2021 and has held it in 9 quarters since.
  • Caprock Group's Insulet position peaked at $2.28M in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.